'Ca 125' diaporamas de présentation

Epithelial Ovarian Carcinoma

Epithelial Ovarian Carcinoma. ??????? ?????. Introduction. Malignant neoplasms of the ovary present an increasing challenge to the physician. They are the cause of more deaths than any other female genital tract cancer. It accounts for 5% of all cancers among women.

683 views • 67 slides

Ovarian neoplasms.

Ovarian neoplasms. Ovarian neoplasms. Anita Chudecka - G?az.

736 views • 57 slides

Hafiz Hassan Ali Ayesha Nazir Khan Gohar Ayub Khan

Tumor Markers. Hafiz Hassan Ali Ayesha Nazir Khan Gohar Ayub Khan. Contents. Introduction Properties of Tumor markers Identification of Tumor markers Potential uses of Tumor markers Types of markers. Introduction

662 views • 53 slides

TUMOR MARKERS

TUMOR MARKERS. Naglaa Fathy Alhusseini Ass.Prof. of Biochemistry and Molecular Biology Nagla.alhusseini@fmed.bu.edu.eg. What are the tumor markers?.

622 views • 52 slides

TUMOR MARKERS

892 views • 49 slides

TUMOR MARKERS

599 views • 48 slides

Tumor markers

1.05k views • 42 slides

Laparoscopic and Robotic Management of the Adnexal Mass Javier Magrina, MD Mayo Clinic in Arizona

Laparoscopic and Robotic Management of the Adnexal Mass Javier Magrina, MD Mayo Clinic in Arizona. JFM072902. JFM100402. Prior to surgery differentiate. Functional vs benign neoplastic Benign vs malignant. Benign neoplastic adnexal masses by age. %. 100. 90. 80. 60. 34. 40. 27. 20.

672 views • 39 slides

Tumour Markers

384 views • 32 slides

Ovarian Cancer 101: Breakout session for recently diagnosed ovarian cancer patients

Ovarian Cancer 101: Breakout session for recently diagnosed ovarian cancer patients. Christopher Morse, MD Fellow, Gynecologic oncology UW MEDICINE. Overview. Introduction to ovarian cancer Diagnosis and treatment Surgery and chemotherapy Surveillance Genetic testing

304 views • 29 slides

Pelvic Mass

Pelvic Mass. Alexander Dufort and Sean Mindra OBGYN boot camp October 17 th , 2014. Objectives. List pelvic tumors of ovarian origin. Classify ovarian pathology as benign vs. malignant. Compare and contrast functional vs. neoplastic ovarian cysts. Case.

1.2k views • 26 slides

Ovarian cancer is the most lethal gynecologic cancer

A prospective U.S. ovarian cancer screening study using the risk of ovarian cancer algorithm (ROCA) K. H. Lu, S. J. Skates, T. B. Bevers, W. Newland, R. G. Moore, L. Leeds, S. Harris, O. W. Adeyinka, H. A. Fritsche, R. C. Bast. Ovarian Cancer.

1.06k views • 24 slides

The post-menopausal simple ovarian cyst

The post-menopausal simple ovarian cyst. Management Strategies. ??' ??? ????, ??"? ??? ???????. Scope of the problem. Ovarian cancer is the leading cause of death from gynecologic cancer in the United States.

717 views • 22 slides

Conflict of Interest

Randomized, double-blind, placebo-controlled phase 2 study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian carcinoma.

390 views • 22 slides

Bioc h emist r y

212 views • 21 slides

Abdominal mass in a pregnancy

Abdominal mass in a pregnancy. - C ase presentation By R3 ???. General & Past History. 35 y/o female Denied past history of systemic disease or op No contributable family/drug/allergy history H: 160cm, W: 54kg Pregnancy ( 6wks ; LMP:2003/3/17 ) with progressive abdominal distention.

376 views • 20 slides

Ovarian cancer and dermatomyositis

582 views • 19 slides

Tumormarkers

Tumormarkers. Tumormarkers. Tumormarkers: ? optimal marker for a given disease? ? optimal time of marker assessment? ? diagnostic tool? Follow-up after therapy?. Tumormarkers Definition. Substances detectable in blood and body fluids of patients with malignant disease.

230 views • 18 slides

CASO

290 views • 7 slides

Whole body PET/CT for the detection of recurrent ovarian cancer Nan-Jing Peng

Whole body PET/CT for the detection of recurrent ovarian cancer Nan-Jing Peng. Abstract:

103 views • 3 slides